Strategy
MSTR
Coinbase
COIN
Tesla
TSLA
Vale SA
VALE
Salesforce
CRM
US Stock MarketDetailed Quotes
NOTV Inotiv
- 2.580
- +0.180+7.50%
Close Mar 11 16:00 ET
- 2.580
- 0.0000.00%
Post 16:05 ET
87.38MMarket Cap-0.56P/E (TTM)
2.640High2.320Low682.47KVolume2.410Open2.400Pre Close1.70MTurnover2.22%Turnover RatioLossP/E (Static)33.87MShares11.41752wk High0.51P/B79.35MFloat Cap1.22752wk Low--Dividend TTM30.76MShs Float60.660Historical High--Div YieldTTM13.33%Amplitude0.597Historical Low2.494Avg Price1Lot Size
About Inotiv Company
Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. It operates under the Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments. The DSA segment focuses on drug discovery and development services. The RMS segment includes commercial production and selling research models, diets, bedding, and bioproducts. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.
Company Profile
SymbolNOTV
Company NameInotiv
Listing DateNov 25, 1997
Issue Price8.00
Founded1974
CEOMr. Robert W. Leasure, Jr
MarketNASDAQ
Employees2075
Fiscal Year Ends09-30
Address2701 Kent Avenue
CityWest Lafayette
ProvinceIndiana
CountryUnited States of America
Zip Code47906-1382
Phone1-765-463-4527
Websitehttp://www.inotivco.com
Company Executives
- Name
- Position
- Salary
- Robert W. Leasure, Jr
- Director, President and Chief Executive Officer
- 1.66M
- Andrea Castetter
- General Counsel, Corporate Secretary and Chief Compliance Officer
- --
- Beth A. Taylor
- Senior Vice President, Finance and Chief Financial Officer
- 483.71K
- Dr. John E. Sagartz, D.V.M.,PhD
- Director and Chief Strategy Officer
- 474.75K
- John Gregory Beattie
- Chief Operating Officer
- --
- Brennan Freeman
- Vice President, Finance, Corporate Controller and Principal Accounting Officer
- --
- Jeffrey Arthur Krupp
- Senior Vice President, Human Resources
- --
- Dr. Adrian Hardy, PhD
- Executive Vice President
- --
- R. Matthew Neff
- Non-Executive Chairman of the Board
- 146.78K
- Terry Coelho
- Independent Director
- 155.42K
- Dr. Nigel Brown, PhD
- Independent Director
- 121.78K
- Michael J. Harrington
- Independent Director
- 89.42K
- David Landman
- Independent Director
- 114.28K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.